Skip to main content
Premium Trial:

Request an Annual Quote

ABI Cuts 13 Mass Spec Staffers in Realignment

This article has been updated from a previous version to provide further details and a comment from a company spokesperson. 
NEW YORK (GenomeWeb News) - Thirty-two ABI employees, 13 of whom are involved in the company’s LC-MS product line, are losing their jobs, the company revealed in its annual report filed with the US Securities and Exchange Commission last month.
The employees were notified by May 31 and are expected to be terminated by Dec. 31, the company said in the filing.
An ABI spokesperson told GenomeWeb Daily News today that the cuts are part of a "rebalancing" of the company's business to place more of a focus on its business in Asia, and particularly China. He added that the global headcount for the company's mass spec business has remained the same or "possibly increased." 
ABI "has not taken any action to reduce the headcount in its mass spec business," he said.
As a result of the reduction in workforce, ABI took a $4.7 million pre-tax charge in its fiscal fourth quarter, ended June 30, for severance costs. The figure includes a $700,000 charge related to the ABI/MDS Analytical Technologies business, resulting from the “realignment of the Applied Biosystems group to support its strategic growth priorities and the decision at MDS to resize and refocus its development process,” ABI said in the filing.
ABI, which is awaiting final approvals for its $6.7 billion merger with Invitrogen, and MDS have a 50/50 joint venture for mass spectrometry instruments.
ABI brought in revenues of $609 million for the three-month period ended June 30, up 9 percent over the fourth quarter of 2007.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.